AUTOIMMUNE DISEASE BIOMARKERS
    4.
    发明申请
    AUTOIMMUNE DISEASE BIOMARKERS 审中-公开
    自杀性疾病生物标志物

    公开(公告)号:US20080254482A1

    公开(公告)日:2008-10-16

    申请号:US11944254

    申请日:2007-11-21

    IPC分类号: G01N33/564

    摘要: Provided herein are novel panels of biomarkers for the diagnosis of autoimmune diseases, and methods and kits for detecting these biomarkers in samples of individuals suspected of having an autoimmune disease. Also provided are methods of monitoring the progression of an autoimmune disease and methods of monitoring the efficacy and side effects of a treatment for an autoimmune disease.

    摘要翻译: 本文提供了用于诊断自身免疫疾病的生物标志物的新颖小组,以及用于在疑似患有自身免疫疾病的个体的样品中检测这些生物标志物的方法和试剂盒。 还提供了监测自身免疫疾病进展的方法以及监测自身免疫疾病治疗的功效和副作用的方法。

    Biomarkers for Osteoarthritis
    5.
    发明申请
    Biomarkers for Osteoarthritis 失效
    骨关节炎生物标志物

    公开(公告)号:US20070225206A1

    公开(公告)日:2007-09-27

    申请号:US11573711

    申请日:2005-08-12

    IPC分类号: G01N33/68

    摘要: Methods are provided for evaluating osteoarthritis (OA), for example for diagnosing OA, to confirm a diagnosis of OA, to assess or prognose progression of OA, determining the severity of a subject who has OA, and determining a subject's risk of developing OA in the future, as are arrays and kits that can be used to practice the methods. In particular examples, the method includes determining an amount of activity (such as an amount of protein present or an amount of expression) of OA risk-related molecules, such as soluble vascular adhesion protein 1 (sVAP-1) or interleukin-15 (IL-15). Also provided are methods of identifying one or more compounds that alter the activity of an OA-related molecule, thereby identifying potential anti-osteoarthritis drugs.

    摘要翻译: 提供了用于评价骨关节炎(OA)的方法,例如用于诊断OA,确认OA的诊断,评估或预测OA的进展,确定具有OA的受试者的严重程度,以及确定受试者发生OA的风险 未来,以及可用于实践方法的数组和工具包。 在具体实例中,该方法包括确定OA风险相关分子(例如可溶性血管粘附蛋白1(sVAP-1))或白细胞介素-15(活性)的活性量(例如存在的蛋白质的量或表达量) IL-15)。 还提供了鉴定一种或多种改变OA相关分子的活性的化合物的方法,从而鉴定潜在的抗骨关节炎药物。